aTyr Pharma Inc. (ATYR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for aTyr Pharma Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$0.13
+3.55% today
Market cap
$12M
Overall quality
43/100
Kronos AI 30-day
—
aTyr Pharma Inc. (ATYR) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $12M. It trades at $0.13, up 3.55% today. Its overall quality score is 43 out of 100, ranked against the whole US market. 4 analysts' average target of $1.00 implies +669.2% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $1.00 |
| Low – high | $1.00 – $1.00 |
| Analysts | 4 |
| Upside to average | +669.2% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 37 |
| Solvency | 56 |
| Growth | 36 |
| Overall | 43 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.